Ronit Kar/LinkedIn
Oct 3, 2025, 16:31
Ronit Kar and Team Used Microfluidic Technology and Found That Platelets From Pediatric Trauma
RPTH Journal shared a post on LinkedIn:
“Existing clinical assays are inadequate to evaluate posttraumatic platelet dysfunction in children.
Ronit Kar and team used microfluidic technology and found that platelets from pediatric trauma patients had reduced deposition compared to controls.”
Title: Beyond the count: platelet dysfunction profile in pediatric trauma patients
Authors: Ronit Kar, Erin V. Feeney, Jack R. Killinger, Katrina M. Morgan, Devin M. Dishong, Katelin C. Rahn, Rassam M.G. Rassam, Grace A. Ballentine, Philip C. Spinella, Matthew D. Neal, Barbara A. Gaines, Susan M. Shea, Christine M. Leeper

Check out their findings here
Stay updated with Hemostasis Today.
Barbara A. Gaines
Christine M. Leeper
Devin M. Dishong
Erin V. Feeney
Grace A. Ballentine
Health
Hematology
Hemostasis
Hemostasis Today
Jack R. Killinger
Katelin C. Rahn
Katrina M. Morgan
Matthew D. Neal
Medicine
Microfluidic Technology
Pediatric Trauma
Philip C. Spinella
Posttraumatic Platelet Dysfunction
Rassam M.G. Rassam
Ronit Kar
RPTH Journal
Susan M. Shea
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis